Literature DB >> 34272511

Eye disease and mortality, cognition, disease, and modifiable risk factors: an umbrella review of meta-analyses of observational studies.

Mike Trott1,2, Lee Smith3, Nicola Veronese4,5, Damiano Pizzol6, Yvonne Barnett7, Trish Gorely8, Shahina Pardhan9.   

Abstract

Globally, 2.2 billion people live with some form of vision impairment and/or eye disease. To date, most systematic reviews examining associations have focused on a single eye disease and there is no systematic evaluation of the relationships between eye diseases and diverse physical and mental health outcomes. Moreover, the strength and reliability of the literature is unclear. We performed an umbrella review of observational studies with meta analyses for any physical and/or mental comorbidities associated with eye disease. For each association, random-effects summary effect size, heterogeneity, small-study effect, excess significance bias and 95% prediction intervals were calculated, and used to grade significant evidence from convincing to weak. 34 studies were included covering 58 outcomes. No outcomes yielded convincing evidence, six outcomes yielded highly suggestive results (cataract positively associated with type 2 diabetes, open-angled glaucoma positively associated with myopia and diabetes, diabetic retinopathy positively associated with cardiovascular disease and cardiovascular mortality, and retinopathy of prematurity positively associated with chorioamnionitis), eight outcomes yielded suggestive results (diabetic retinopathy positively associated with all-cause mortality and depression, diabetic macular oedema positively associated with dyslipidaemia, cataract positively associated with gout, nuclear sclerosis positively associated with all-cause mortality, open angled glaucoma positively associated with migraine and hypertension, and age-related macular degeneration positively associated with diabetes), and 18 outcomes yielded weak evidence. Results show highly suggestive or suggestive evidence for associations between several types of eye diseases with several comorbid outcomes. Practitioners and public health policies should note these findings when developing healthcare policies.
© 2021. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.

Entities:  

Mesh:

Year:  2021        PMID: 34272511      PMCID: PMC8807837          DOI: 10.1038/s41433-021-01684-x

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   4.456


  59 in total

1.  High cardiovascular disease mortality in subjects with visual impairment caused by diabetic retinopathy.

Authors:  U Rajala; H Pajunpää; P Koskela; S Keinänen-Kiukaanniemi
Journal:  Diabetes Care       Date:  2000-07       Impact factor: 19.112

2.  Global Prevalence of Presbyopia and Vision Impairment from Uncorrected Presbyopia: Systematic Review, Meta-analysis, and Modelling.

Authors:  Timothy R Fricke; Nina Tahhan; Serge Resnikoff; Eric Papas; Anthea Burnett; Suit May Ho; Thomas Naduvilath; Kovin S Naidoo
Journal:  Ophthalmology       Date:  2018-05-09       Impact factor: 12.079

3.  Visual impairment and incident mobility limitations: the health, aging and body composition study.

Authors:  Bonnielin K Swenor; Eleanor M Simonsick; Luigi Ferrucci; Anne B Newman; Susan Rubin; Valerie Wilson
Journal:  J Am Geriatr Soc       Date:  2014-12-23       Impact factor: 5.562

4.  Age-Related Macular Degeneration in Chronic Kidney Disease: A Meta-Analysis of Observational Studies.

Authors:  Yi-Ju Chen; Ling Yeung; Chi-Chin Sun; Chien-Chieh Huang; Kuo-Su Chen; Yi-Hsuan Lu
Journal:  Am J Nephrol       Date:  2018-10-18       Impact factor: 3.754

Review 5.  Association between glaucoma and obstructive sleep apnea syndrome: a meta-analysis and systematic review.

Authors:  Yuhua Shi; Panpan Liu; Jian Guan; Yan Lu; Kaiming Su
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

6.  The association between gout and cataract risk: A meta-analysis.

Authors:  Chenqi Luo; Xinyi Chen; Hongchuan Jin; Ke Yao
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

Review 7.  Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis.

Authors:  Rupert R A Bourne; Seth R Flaxman; Tasanee Braithwaite; Maria V Cicinelli; Aditi Das; Jost B Jonas; Jill Keeffe; John H Kempen; Janet Leasher; Hans Limburg; Kovin Naidoo; Konrad Pesudovs; Serge Resnikoff; Alex Silvester; Gretchen A Stevens; Nina Tahhan; Tien Y Wong; Hugh R Taylor
Journal:  Lancet Glob Health       Date:  2017-08-02       Impact factor: 26.763

8.  Suicides in Visually Impaired Persons: A Nation-Wide Register-Linked Study from Finland Based on Thirty Years of Data.

Authors:  Victor Benno Meyer-Rochow; Helinä Hakko; Matti Ojamo; Hannu Uusitalo; Markku Timonen
Journal:  PLoS One       Date:  2015-10-28       Impact factor: 3.240

9.  Visual Impairment, Hearing Loss and Cognitive Function in an Older Population: Longitudinal Findings from the Blue Mountains Eye Study.

Authors:  Thomas Hong; Paul Mitchell; George Burlutsky; Gerald Liew; Jie Jin Wang
Journal:  PLoS One       Date:  2016-01-25       Impact factor: 3.240

10.  Visual impairment and risk of depression: A longitudinal follow-up study using a national sample cohort.

Authors:  Hyo Geun Choi; Min Joung Lee; Sang-Mok Lee
Journal:  Sci Rep       Date:  2018-02-01       Impact factor: 4.379

View more
  2 in total

1.  Virtual reality training improves accommodative facility and accommodative range.

Authors:  Dong-Yu Guo; Yuan-Yuan Shen; Miao-Miao Zhu; Yang-Yang Zhan; Xia-Wei Wang; Jian-Hua Xia; Bo Jiang; Yang-Shun Gu; Yan Long
Journal:  Int J Ophthalmol       Date:  2022-07-18       Impact factor: 1.645

2.  Temporal trajectories of important diseases in the life course and premature mortality in the UK Biobank.

Authors:  Xianwen Shang; Xueli Zhang; Yu Huang; Zhuoting Zhu; Xiayin Zhang; Shunming Liu; Jiahao Liu; Shulin Tang; Wei Wang; Honghua Yu; Zongyuan Ge; Mingguang He
Journal:  BMC Med       Date:  2022-05-27       Impact factor: 11.150

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.